Treatment with mogamulizumab or lenalidomide for relapsed adult T‐cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience

Author:

Sakamoto Hikaru12,Itonaga Hidehiro3ORCID,Sawayama Yasushi2,Furumoto Takafumi4,Fujioka Machiko12,Chiwata Masahiko1,Toriyama Eo14,Kasai Sachie1,Nakashima Jun5,Horai Makiko2,Kato Takeharu6,Sato Shinya2,Ando Koji3,Taguchi Jun7,Imaizumi Yoshitaka2,Yoshida Shinichiro6,Hata Tomoko3,Moriuchi Yukiyoshi4,Miyazaki Yasushi132

Affiliation:

1. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

2. Department of Hematology Nagasaki University Hospital Nagasaki Japan

3. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute Nagasaki University Nagasaki Japan

4. Department of Hematology Sasebo City General Hospital Sasebo Japan

5. Department of Hematology Japan Community Health care Organization Isahaya General Hospital Isahaya Japan

6. Department of Hematology National Hospital Organization Nagasaki Medical Center Omura Japan

7. Department of Hematology Japanese Red Cross Nagasaki Genbaku Hospital Nagasaki Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3